Skip to main content
Overall Survival Gain With Adding Darolutamide to ADT and Docetaxel in Metastatic, Hormone-Sensitive Prostate Cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Overall Survival Gain With Adding Darolutamide to ADT and Docetaxel in Metastatic, Hormone-Sensitive Prostate Cancer
User login
Username
Password
Reset your password
Concept
Lead
score
Prostate Cancer
1
0.8
Bone Metastasis
0
0.74
Metastasis
0
0.64
Bone
0
0.38
Bone Scan
0
0.38
Prostate
0
0.38
Toxicology
0
0.38
Opioids
0
0.33
Lymph Node
0
0.29
Skeletal
0
0.29
CT Scan
0
0.26
Specialty
Lead
score
Hematology-Oncology
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Neurology & Neurosurgery
0
1
Orthopaedics
0
0.99
Pharmacist
0
0.89
Radiology
0
0.79
Emergency Medicine
0
0.73
Urology
0
0.72
Public Health & Prevention
0
0.63
Dermatology
0
0.62
Nursing
0
0.62
Anesthesiology
0
0.28
Edit Tags